CVE-2025-36227

CVE-2025-36227 is a medium-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 5.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-644.

Key facts

Description

IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to HTTP header injection, caused by improper validation of input by the HOST headers.  This could allow an attacker to conduct various attacks against the vulnerable system, including cross-site scripting, cache poisoning or session hijacking.

Frequently asked questions

What is CVE-2025-36227?
IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to HTTP header injection, caused by improper validation of input by the HOST headers.  This could allow an attacker to conduct various attacks against the vulnerable system, including cross-site scripting, cache poisoning or session hijacking.
How severe is CVE-2025-36227?
CVE-2025-36227 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2025-36227 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (11th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-36227?
CVE-2025-36227 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-36227?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-36227 have an EU (EUVD) identifier?
Yes. CVE-2025-36227 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-208514.
When was CVE-2025-36227 published?
CVE-2025-36227 was published on 2026-03-10 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Ibm Aspera Faspex

All CVEs affecting Ibm Aspera Faspex →

Other CWE-644 vulnerabilities

Browse all CWE-644 vulnerabilities →